EMA Mulls Dropping Comparative Efficacy Trials For Biosimilars

European Agency Kicks Off Consultation On Whether Such Studies Are Always Necessary

 
• By Dave Wallace
  
Unnecessary necessary word wooden blocks
Are comparative efficacy studies necessary for all biosimilars? • Source: Shutterstock

More from Biosimilars

More from Products